Results 81 to 90 of about 23,130 (165)

Correction: Regioselective synthesis of aza-saccharins <i>via</i> anionic [1,4] Fries-type rearrangement of aryl sulfonimidoyl fluorides. [PDF]

Chem Sci
Leypold M, Poli L, Earl M, Putra OD, Kwapien K, Lewis RJ, Murphy JJ, Passamonti M, von Sydow LM, Spelling V, Asproudis I, Sardana M, Gatti C, Seki H, Lemaitre T, Juskaite R, Gopalakrishnan R, Francis SJ, Gardelli C, Norrby PO, Czechtizky W.   +20 more
europepmc   +1 more source

The first oral relaxin receptor RXFP1 agonist for heart failure treatment: Translational studies from non-human primates to humans. [PDF]

Mol Ther Adv
Ryberg E, Bergström F, Sten S, Olsson J, Lal M, Connolly K, Matsson E, Åstrand M, Althage M, Hartman RJG, Mohamed E, Fjellstrom O, Pettersen D, George RT, Whittaker A, Kujacic M, Gabrielsen A, Rosenmeier JB.   +17 more
europepmc   +1 more source

Benralizumab reduces sputum ANCA in patients with eosinophilic granulomatosis with polyangiitis. [PDF]

ERJ Open Res
Mukherjee M, Tan NS, Huang C, Kim B, Radford K, Ju X, Venegas Garrido C, Kjarsgaard M, Rodríguez-Suárez E, Wechsler ME, Walker B, Börjesson Sjö L, Necander S, Ashkar A, Weidner J, Sehmi R, McCrae C, Khalidi N, Nair P.   +18 more
europepmc   +1 more source

Safety and Pharmacokinetics of Nirsevimab in Japanese Infants: Primary Analysis of the Open-Label JUBILUS Trial. [PDF]

J Pediatric Infect Dis Soc
Mori M, Leach S, Learoyd M, Vijapur D, Sadow S, Wilkins D, Abe Y, Ikeda K, Kanegane H, Kano Z, Moriuchi H, Muneuchi J, Nishikomori R, Okazaki K, Takas T, Sakaguchi A, Villafana T.   +16 more
europepmc   +1 more source

Omics-aided design genome editing strategy for challenging human immortalized cell models. [PDF]

PLoS One
Mendoza-Garcia P, Keith B, Nordberg M, Quist E, Ferrás C, Hamza GM, Elgendy R, Ashenden SK, Chi J, van Zuydam NR, Hattersley N, Zhang X.   +11 more
europepmc   +1 more source

Anifrolumab Treatment Leads to Rapid Reduction in Urinary Biomarkers of Intrarenal Inflammation in Lupus Nephritis: Results From the Phase 2 Randomized Trial. [PDF]

Arthritis Rheumatol
Fava A, Petri M, Gavin PG, Csomor E, Brohawn PZ, Muthas D, Platt A, Lindholm C, Ferrari N.   +8 more
europepmc   +1 more source

Epidemiology, clinical management, and outcomes in patients with eosinophilic granulomatosis with polyangiitis in England: A retrospective observational cohort study. [PDF]

J Allergy Clin Immunol Glob
Siddiqui S, Ding B, Dolin P, Edmonds C, Jain P, Rowell J, Westerink L, Lacetera A, Suárez-Sánchez P, Ariti C, Podmore B, Kitchin Velarde A, Chen SY.   +12 more
europepmc   +1 more source

Preclinical characterization of AZD1163, a first-in-class anti-PAD2/4 bispecific antibody for the treatment of rheumatoid arthritis. [PDF]

MAbs
Sims GP, Scaletta L, Andrews J, Sims DA, Strain M, Sigurdardottir A, Kuriakose T, England E, Rajasinghe L, Jiang F, Xiong X, Neal F, Vinall L, Newton P, Boger E, Kim C, Dahlbäck H, Prothon S, Leander J, Darrah E, Collins M, Douglas G, White N, Day K, Vousden KA, Huntington CE, Close D.   +26 more
europepmc   +1 more source

Letter to the Editor Regarding "Comparative Effectiveness of FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up From Dual Therapy". [PDF]

Adv Ther
Quint J, Varghese D, Mullerova H, Marshall J.   +3 more
europepmc   +1 more source

Pharmacokinetic and Biopharmaceutic Terminology [PDF]

Drug Intelligence & Clinical Pharmacy, 1977
openaire   +2 more sources